
DeSimone holds more than 130 patents. His current projects include developing a nanoparticle vaccine for prostate cancer and creating particles that mimic red blood cells. He is a member of the UNC Lineberger Comprehensive Cancer Center and an adjunct member at Memorial Sloan-Kettering Cancer Center in New York. He also is co-founder of Liquidia Technologies, a Triangle-based nanotechnology company. Read more.
P.S. First-year students: If you haven't already, don't forget to enroll today by 11:59 p.m. EDT.